UNIFORM FILMS FOR RAPID DISSOLVE DOSAGE FORM INCORPORATING TASTE-MASKING COMPOSITIONS

Methods of adminstering elagolix

Estrogen combination for treatment of multiple sclerosis

Method for differentially diagnosing ACTH-dependent Cushing's syndrome

NOVEL ESTROGEN RECEPTOR MUTATIONS AND USES THEREOF

TRANSDERMAL DRUG DELIVERY SYSTEMS FOR LEVONORGESTREL AND ETHINYL ESTRADIOL

Compounds and methods for treating aberrant adrenocortical cell disorders

UNIFORM, HIGH BASIS WEIGHT NANOFIBER FABRICS FOR MEDICAL APPLICATIONS

Cosmetic and Pharmaceutical Foam

Pharmaceutical Compositions Affecting Mitochondrial Redox State and Methods of Treatment

Methods and compositions for modulating hormone levels

Controlled release fatty acid compositions for use in body reconstruction and body-shaping

Antihistamines in combination with a range of substances for improved health

Optimizing mifepristone levels for cushing's patients

Transdermal drug delivery systems for levonorgestrel and ethinyl estradiol

PROGESTERONE RECEPTOR ANTAGONIST DOSAGE FORM

Drug delivery system for delivery of anti-virals

Cytotoxic agents that preferentially target leukemia inhibitory factor (LIF) for the treatment of malignancies and as new contraceptive agents

ESTROGEN RECEPTOR MODULATORS FOR REDUCING BODY WEIGHT

INTRAUTERINE DELIVERY SYSTEM

DERMAL DELIVERY COMPOSITIONS AND METHODS

Pharmaceutical combinations for the treatment of cancer

Onapristone extended-release compositions and methods

Method and Composition for Treating Inflammatory Disorders

Method of treatment for prostate cancer with androgen receptor antagonists and glucocorticoid receptor antagonists

CLASSIFICATION SYSTEM, METHODS AND KIT FOR CLASSIFYING, PREDICTING AND TREATING BREAST CANCER

Estrogen receptor mutations and uses thereof

Transdermal contraceptive hormones delivery

Compounds and methods for trans-membrane delivery of molecules

Pharmaceutical composition comprising progestogens and/or estrogens and 5-methyl-(6S)-tetrahydrofolate

Secnidazole for use in the treatment of bacterial vaginosis

Methods for manufacturing implants

Compositions and methods for transdermal delivery of hormones and other medicinal agents

Transdermal contraceptive hormones delivery

FORMULATION OF AMORPHOUS CALCIUM L-5-METHYLTETRAHYDROFOLATE (L-5-MTHF-Ca)

Progesterone receptor modulators for use in the therapy of uterine fibroids

Methods for increasing efficacy of lipid formulated siRNA

Therapeutic and method of use

Treatment of endometriosis

Compounds and methods for treating aberrant adrenocortical cell disorders

Use and application regimen of a pharmaceutical composition containing levonorgestrel and a COX inhibitor for on-demand contraception

Core sheath drug delivery devices

Film-forming pharmaceutical composition for wound healing and method for preparing the same

Intrauterine device and method for reducing the rate of diffusion of active ingredients in said device by adding inert particulates to a polymeric coating

Methods and materials for reducing suppression of immune function

PARENTERAL PHARMACEUTICAL FORM WHICH RELEASES AROMATSE INHIBITOR AND GESTAGENS, FOR THE TREATMENT OF ENDOMETRIOSIS

Lipolytic methods

Methods and compositions for treating trauma-hemorrhage using estrogen and derivatives thereof

17-hydroxy-17-pentafluoroethyl-estra-4,9(10)-dien-11-aryl derivatives, method of production thereof and use thereof for the treatment of diseases

UV STABLE TRANSDERMAL PLASTER

Systems and methods of managing treatment of a chronic condition by symptom tracking

Combination of (3S,3S′) 4,4′-disulfanediylbis(3-aminobutane 1-sulfonic acid) and a second antihypertensive agent

Diagnosis and treatment of endometriosis and related conditions

Pharmaceutical compositions comprising active drugs, contraceptive kits comprising active drugs, and methods of administering the same

Synergistic anti-cancer composition and a process for the preparation thereof

Levonorgestrel-Only-Composition For Optimized Oral Contraception With Defined Levonorgestrel Content, Dosage Regimen And Pharmaceutical Preparation

Hormone Normalization Therapy and Uses Therefor

Transdermal nicotine salt delivery system

Corticosteroid compositions

Combination therapies and methods of use thereof for treating cancer

COMBINATION THERAPIES COMPRISING ANTI-ERBB3 AGENTS

Methods and compositions for treating antiprogestin-resistant cancers

Inhalation compositions comprising glucose anhydrous

UNIFORM FILMS FOR RAPID DISSOLVE DOSAGE FORM INCORPORATING TASTE-MASKING COMPOSITIONS

BIODEGRADABLE DRUG DELIVERY FOR HYDROPHOBIC COMPOSITIONS

MULTI-LAYERED TRANSDERMAL SYSTEM WITH TRIAZINE UV ABSORBER

FORMULATIONS FOR THE PREPARATION OF IMMEDIATE RELEASE TABLETS FOR ORAL ADMINISTRATION CONTAINING LOW-DOSE MIFEPRISTONE, TABLETS THUS OBTAINED AND THEIR PREPARATION PROCESS

Combination therapy intravaginal rings

Estrogenic components for use in the treatment of neurological disorders

Pharmaceutical composition or group of compositions for inhibiting autocrine HCG production in adult human cells

Pharmaceutical Combination of Resveratrol and Progestin to Treat and/or Prevent Myoma and/or Endometriosis

Methods for treating polycystic kidney disease and polycystic liver disease

Pharmaceutical composition for emergency contraception

Steroid Sulfatase Inhibitor Regimen for the Treatment of Endometriosis

Method of treatment of prostate cancer with androgen receptor and glucocorticoid receptor antagonists

CORTICOSTEROID COMPOSITIONS

DERMAL DELIVERY DEVICE WITH IN SITU SEAL

Therapeutic and method of use

METHODS AND COMPOSITIONS RELATED TO GLUCOCORTICOID RECEPTOR ANTAGONISTS AND BREAST CANCER

Lipolytic methods

Methods and compositions related to glucocorticoid receptor antagonists and breast cancer

STEROID HORMONE PRODUCTS AND METHODS FOR PREPARING THEM

Adhesive patch assembly with overlay liner and system and method for making same

Multiphasic contraceptive regimen for oral combination drug formulation of progestin and estrogen

Method for treatment of mesothelioma

Device for transdermal administration of drugs including acrylic polymers

CONTRACEPTIVE METHOD

High enhancer-loading polyacrylate formulation for transdermal applications

ACTIVE INGREDIENT COMBINATION OF A RETINOID AND A HORMONE COMBINATION WITH CONTRACEPTIVE ACTION AS MEDICAMENT FOR TREATMENT OF SKIN DISEASES

COMPOSITIONS AND METHODS FOR CONTROLLING DRUG LOSS AND DELIVERY IN TRANSDERMAL DRUG DELIVERY SYSTEMS

Foamable carriers

METHODS, DOSING REGIMENS AND MEDICATIONS USING ANTI-PROGESTATIONAL AGENTS FOR THE TREATMENT OF DISORDERS

Tablet containing dehydroepiandrosterone (DHEA)

Composition for prevention or treatment of ischemic cardiac disease, comprising inhibitor against age-albumin synthesis or release of mononuclear phagocyte system cells as active ingredient

NOVEL ESTROGEN RECEPTOR MUTATIONS AND USES THEREOF

INTRAVAGINAL DEVICES FOR DRUG DELIVERY

Estrus synchronization preparations and effective CIDR-less protocols

Tanaproget Compositions Containing Ethinyl Estradiol

Methods and compositions related to glucocorticoid receptor antagonists and breast cancer

Transdermal drug delivery systems for levonorgestrel and ethinyl estradiol

Compositions for treating CMT and related disorders

Compositions and methods for transdermal delivery of hormones and other medicinal agents

Combination hormone replacement therapy (HRT) and melatonin to prevent and treat mammary cancer

Vaginal matrices: nanofibers for contraception and prevention of HIV infection

Intrauterine delivery system for contraception

Transdermal delivery of hormones with low concentration of penetration enhancers

SELECTIVE CNS DELIVERY OF MIFEPRISTONE (RU486) TO MODULATE THE TIMING OF THE SPONTANEOUS LH SURGE DURING FOLLICULAR STIMULATION CYCLES

Inhibitors of 17β-HSD1, 17β-HSD3 and 17β-HSD10

USE OF ANDROGEN FOR DISEASE TREATMENT

Combination therapies comprising anti-ERBB3 agents

PHARMACEUTICAL COMPOSITION FOR USE AS A CONTRACEPTIVE

Triterpene-containing oleogel-forming agent, triterpene-containing oleogel and method for producing a triterpene-containing oleogel

Methods for using mifepristone to reduce the number of CD14/DR-monocytes

Treatment of Ocular Diseases

Methods and compositions for cancer prevention and treatment

Compounds and methods for treating aberrant adrenocartical cell disorders

Formulation For Hormonotherapy

Drug Combination Comprising a Selective Serotonin Reuptake Inhibitor and a Glucocorticoid Receptor Antagonist for the Treatment of Depression

Therapeutic Gestagens For The Treatment Of Premenstrual Dysphoric Disorder

Core sheath drug delivery devices

Pharmaceutical composition containing a tetrahydrofolic acid

Hormonal composition and its use

Recovery and processing of human embryos formed in vivo

Optimizing mifepristone absorption

Dermal delivery compositions and methods

Neuroprotection and myelin repair using nestorone®

Drug delivery system

Methods and systems for identifying and treating anti-progestin sensitive tumors

ONCE-A-MONTH METHOD OF CONTRACEPTION

METHOD OF PREVENTIVE ON-DEMAND HORMONAL CONTRACEPTION

Drug delivery system

Dermal delivery device with in situ seal

Oral contraceptives to prevent pregnancy and diminish premenstrual symptomatology

METHOD FOR THE TREATMENT OF CANCER

Device for transdermal administration of drugs including acrylic polymers

Methods of hormonal treatment utilizing ascending-dose extended cycle regimens

Methods for increasing efficacy of lipid formulated siRNA

LUBIPROSTONE FOR OBSTETRICAL OR GYNECOLOGICAL APPLICATIONS

MANAGEMENT OF BREAKTHROUGH BLEEDING IN EXTENDED HORMONAL CONTRACEPTIVE REGIMENS

Transdermal levonorgestrel device and delivery

Methods and formulations for treating ineffective or decreased esophagal motility

Pharmaceutical composition for emergency contraception

17-HYDROXY-17-PENTAFLUOROETHYL-ESTRA-4,9(10)-DIEN-11-ARYL DERIVATIVES, METHOD OF PRODUCTION THEREOF AND USE THEREOF FOR THE TREATMENT OF DISEASES

Contraception process and administration form for the same

Pharmaceutical compositions comprising active drugs, contraceptive kits comprising active drugs, and methods of administering the same

METHODS, DOSING REGIMENS AND MEDICATIONS USING ANTI-PROGESTATIONAL AGENTS FOR THE TREATMENT OF DISORDERS

Tanaproget compositions containing ethinyl estradiol

17-hydroxy-17-pentafluoroethyl-estra-4,9(10)-dien-11-aryl derivatives, method of production thereof and use thereof for the treatment of diseases

COMPOSITIONS FOR TREATING CMT AND RELATED DISORDERS

Steroid compounds and treatment methods

Anti-aging agents and methods to identify them

Growth promotion of animals by simultaneous release of steroid compounds from a device

Dosage Form for Hormonal Contraception

Estrus Synchronization Preparations & Effective CIDR-Less Protocols

Lipolytic methods for regional adiposity comprising salmeterol or formoterol

Method and composition for treating nodulocystic and conglobate acne vulgaris

Therapeutic Gestagens for the Treatment of Premenstrual Dysphoric Disorder

Contraceptive transdermal delivery of hormones

THERAPIES FOR TREATING CANCER USING COMBINATIONS OF COX-2 INHIBITORS AND AROMATASE INHIBITORS OR COMBINATIONS OF COX-2 INHIBITORS AND ESTROGEN RECEPTOR ANTAGONISTS

Lipolytic methods for regional adiposity

Estriol Therapy for Autoimmune and Neurodegenerative Disease and Disorders

Nitrate esters of corticoid compounds useful as diuretics

Treatment of muscular dystrophy

Methods and compositions related to glucocorticoid receptor antagonists and breast cancer

Contraceptive transdermal delivery of hormones

COMPOSITIONS AND MEANS FOR TREATING UTERINE LEIOMYOMATA, LEIOMYOMA, MYOMA, UTERINE FIBROIDS, ENDOMETRIOSIS, ADENOMYOSIS AND RELATED DISORDERS BY MIFEPRISTONE

9-ALPHA ESTRATRIENE DERIVATIVES AS ER-BETA SELECTIVE LIGANDS FOR THE PREVENTION AND TREATMENT OF INTESTINAL CANCER

USE OF MIFEPRISTONE FOR THE TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS

Transdermal systems containing multilayer adhesive matrices to modify drug delivery

INTRAUTERINE DELIVERY SYSTEM FOR CONTRACEPTION

Antiglucocorticoid therapy for the prevention of neurological damage in premature infants

METHODS OF HORMONAL TREATMENT UTILIZING CONTRACEPTIVE REGIMENS WITH CONTINUOUS ESTROGEN ADMINISTRATION

Sequential administration of 20,20,21,21,21-pentafluoro-17-hydroxy-11Beta-[4-(hydroxyacetyl)phenyl]-19-nor-17Alpha-pregna-4,9-dien-3-one and one or more progestogens for the treatment of gynaecological disorders

Methods of using lipolytic formulations for regional adipose tissue treatment

Steroid compounds and formulations

Graduated estrogen contraceptive

STEROID HORMONE PRODUCTS AND METHODS FOR PREPARING THEM

STEROID HORMONE PRODUCTS AND METHODS FOR PREPARING THEM

Combination hormone replacement therapy (HRT) and melatonin to prevent and treat mammary cancer

Pharmaceutical containing a hormone combination having a contraceptive effect and an insulin sensitizer

COMPOSITION COMPRISING A COMBINATION OF AN AROMATASE INHIBITOR, A PROGESTIN AND AN OESTROGEN AND ITS USE FOR THE TREATMENT OF ENDOMETRIOSIS

COMPOSITIONS AND METHODS FOR CONTROLLING DRUG LOSS AND DELIVERY IN TRANSDERMAL DRUG DELIVERY SYSTEMS

Oral contraceptives to prevent pregnancy and diminish premenstrual symptomatology

INHIBITORS OF EPPIN/SEMENOGELIN BINDING AS MALE CONTRACEPTIVES

METHOD FOR TREATING CUSHING'S SYNDROME

Anti aging agents and methods to identify them

Dermal delivery device with reduced loss of its volatile components

Cancer treatment methods

Treatment of Oestrogen Dependant Conditions in Pre-menopausal Women

Progesterone antagonist and selective progesterone modulator in the treatment of excessive uterine bleeding

EXTENDED ESTROGEN DOSING CONTRACEPTIVE REGIMEN

Transdermal therapeutic system comprising norelestromin for contraception and hormone replacement

Treatment of Macular Degeneration

QUINAZOLINE INHIBITORS OF EGFR TYROSINE KINASE

PHTHALAZINONE MODULATORS OF H1 RECEPTORS AND/OR LTC4 RECEPTORS

Progestational 3-(6,6-ethylene-17B-hydroxy-3-oxo-17A-pregna-4-ene-17A-yl)propionic acid G-lactones

Monounsaturated fatty acids and perhydrocyclopentanophenanthrene nucleus combination molecules, and their precursors, and the use of all of these as weight-loss agents

Drug comprising at least one gestagen

Isolated Isomers of Norelgestromin and Methods of Making and Using the Same

ACTIVE INGREDIENT COMBINATION OF A RETINOID AND A HORMONE COMBINATION WITH CONTRACEPTIVE ACTION AS MEDICAMENT FOR TREATMENT OF SKIN DISEASES

Estriol Therapy for Autoimmune and Neurodegenerative Disease and Disorders

Extended cycle multiphasic oral contraceptive kit

Method and composition for treating inflammatory disorders

Dosage Regimens and Pharmaceutical Compositions and Packages for Emergency Contraception

ORAL CONTRACEPTIVE SPRAY

Combination of gestagen and insulin sensitizer for treating PCOS

Process for Producing a Single-phase Pharmaceutical Preparation for Limiting/Reducing the Risk of Deep Venous Thrombosis in Association with Oral Contraception

ORAL CONTRACEPTION (LONG-CYCLE REGIMEN AND 21-DAYS-REGIMEN WITH 30 MG ETHINYLESTRADIOL AND 2 MG DIENOGEST) WITHOUT TREATMENT OF THROMBOSIS/HEMOSTASIS

Optimizing mifepristone levels in plasma serum of patients suffering from mental disorders treatable with glucocorticoid receptor antagonists

Anti Mineralocorticoid Therapy of Infection

PHARMACEUTICAL COMPOSITION FOR CONTRACEPTION AND BLOOD PRESSURE REGULATION, KIT FOR CONTRACEPTION CONTAINING SAME AND METHOD OF PRODUCTION OF SAME

Antiglucocorticoid Therapy for the Prevention of Neurological Damage in Premature Infants

PROGESTERONE-RECEPTOR ANTAGONIST FOR USE IN BRCA ALONE OR AS COMBINATION WITH ANTIESTROGEN

Gynecological pharmaceutics- containing microspherical vascular suppository of sodium alginate and its preparation method

USE OF C3-C10 17ALFA-ESTERS OF 9,11-DEHYDROCORTEXOLONE AS ANTI-GONADOTROPHIC AGENTS

Contraceptive

Method of particle formation

Medicament Comprising A Hormone Combination

PHARMACEUTICAL PRODUCTS CONTAINING HORMONES AND A 25-HYDROXY VITAMIN D COMPOUND

PHARMACEUTICAL PRODUCTS CONTAINING HORMONES AND A 25-HYDROXY VITAMIN D COMPOUND

Method of Preventive On-Demand Hormonal Contraception

Transdermal Systems Containing Multilayer Adhesive Matrices to Modify Drug Delivery

PHARMACEUTICAL COMPOSITION FOR CONTRACEPTION AND FOR REDUCING THE RISK OF CONGENITAL ABNORMALITIES

COMBINATION OF PROGESTERONE-RECEPTOR ANTAGONIST TOGETHER WITH NONE-STEROIDAL ANTIESTROGEN FOR USE IN BRCA MEDIATED DISEASES

Dosage form for hormonal contraception

Drug Combination Comprising A Selective Serotonin Reuptake Inhibitor And A Glucocorticoid Receptor Antagonist For The Treatment Of Depression

Extended Use Combination Comprising Estrogens And Progestins

PHARMACEUTICAL PRODUCT CONTAINING PROGESTIN, GENISTEIN, AND VITAMIN D COMPOUND

Inhibition of HIV-1 Replication by Disruption of the Processing of the Viral Capsid-Spacer Peptide 1 Protein

Regimens for Controlled Drug Delivery Devices for Contraception

Inhibition of Hiv-1 Replication by Disruption of the Processing of the Viral Capsid-Spacer Peptide 1 Protein

Breast and prostate cancer treatment method

Enhanced drug delivery in transdermal systems

Enhanced drug delivery in transdermal systems

COMPOSITION CONTAINING PROGESTIN, PHYTOESTROGEN AND ESTROGEN

PHARMACEUTICAL PRODUCT CONTAINING PROGESTIN, GENISTEIN, AND VITAMIN D COMPOUND

COMPOSITION CONTAINING PROGESTIN, PHYTOESTROGEN, ESTROGEN AND VITAMIN D COMPOUND

COMPOSITION CONTAINING PROGESTIN, PHYTOESTROGEN AND VITAMIN D

PHARMACEUTICAL COMPOSITION COMPRISING PROGESTOGENS AND/OR ESTROGENS AND 5-METHYL-(6S)-TETRAHYDROFOLATE

Cosmetic and pharmaceutical foam

Oral contraceptives to prevent pregnancy and diminish premenstrual symptomatology

Methods of hormonal treatment utilizing ascending-dose extended cycle regimens

METHODS TO ADMINISTER SOLID DOSAGE FORMS OF ETHINYL ESTRADIOL AND PRODRUGS THEREOF WITH IMPROVED BIOAVAILABILITY

Oral contraceptives to prevent pregnancy and diminish premenstrual symptomatology

Formulations

Suppression of estrus in mares by a single injection method

PREVENTION OF OVARIAN CANCER BY ADMINISTRATION OF PRODUCTS THAT INDUCE BIOLOGICAL EFFECTS IN THE OVARIAN EPITHELIUM

Uniform films for rapid dissolve dosage form incorporating taste-masking compositions

LOW-DOSAGE PERORAL MEDICATION FOR CONTRACEPTION CONTAINING CRYSTALLINE DIENOGEST AND ETHINYL ESTRADIOL

Pharmaceutical composition containing a tetrahydrofolic acid

Pharmaceutical compositions

Triterpene-containing oleogel-forming agent, triterpene-containing oleogel and method for producing a triterpene-containing oleogel

METHODS TO ADMINISTER ETHINYL ESTRADIOL AND PRODRUGS THEREOF WITH IMPROVED BIOAVAILABILITY

Composition containing Vitamin D and phytoestrogens

Contraceptive and Acne Medication Combination and Treatment of Acne and Other Diseases with Reduced Side Effects

COMPOSITION COMPRISING ANTIPROGESTINS AND PURE ANTIESTROGENS FOR PROPHYLAXIS AND TREATMENT OF HORMONE-DEPENDENT DISEASES

PREVENTION OF OVARIAN CANCER BY ADMINISTRATION OF AGENTS THAT INDUCE BIOLOGIC RESPONSES

Methods, dosing regimens and medications using anti-progestational agents for the treatment of disorders

Extended cycle multiphasic oral contraceptive method

Use of sex steroid function modulators to treat wounds and fibrotic disorders

Method of preventive on-demand hormonal contraception

Methods of Hormonal Treatment Utilizing Ascending-Dose Extended Cycle Regimens

High enhancer-loading polyacrylate formulation for transdermal applications

Compositions of estrogen-cyclodextrin complexes

Method of making a single-stage pharmaceutical preparation for oral therapy of dysfunctional uterine bleeding, containing ethinyl estradiol and dienogest

Solid peroral contraceptive preparations

Control of induced elevated intraocular pressure

Estrogen compositions and therapeutic methods of use thereof

Sustained release enhanced lipolytic formulation for regional adipose tissue treatment

Quadraphasis continuous graduated estrogen contraceptive

HRT formulations

Tanaproget compositions containing ethinyl estradiol

Drug delivery system

Rapidly-dissolving pharmaceutical composition for inhibiting ovulation

Stability of progestogen formulations

UV stable transdermal therapeutic plaster with a UV absorbing adhesive layer separated from the drug matrix

Multi-layered transdermal system with triazine UV absorber

Extended estrogen dosing contraceptive regimen

Solid peroral contraceptive preparations

Estrogenic compounds as anti-mitotic agents

Pharmaceutical preparation for oral contraception

Cosmetic Composition and Method

Composition comprising a combination of an aromatase inhibitor, a progestin and an oestrogen and its use for the treatment of endometriosis

Cosmetic and pharmaceutical foam

Methods of hormonal treatment utilizing ascending-dose extended cycle regimens

Immediate-release pharmaceutical dosage form comprising polymorphous tibolone

Estrogenic compounds as anti-mitotic agents

Method of female hormonal contraception using a fixed extended cycle hormonal preparation containing dienogest and ethinyl estradiol

Device for transdermal administration of drugs including acrylic polymers

Pharmaceutical composition for use as a contraceptive

Oral contraceptive multivitamin compound and methods of administration

Control of a biological function

Remedy for hormone-dependent cancer

Estradiol-related compounds and methods of use as anti-tumor agents

Therapeutic gestagens for the treatment of premenstrual dysphoric disorder

Body cavity foams

Hormonal contraceptive containing a combination of ethinyloestradiol and chlormadinone acetate

Hormonal contraceptive containing a combination of ethinyloestradiol and chlormadinone acetate

Use of a combination of ethinyloestradiol and chlormadinone acetate to produce a pharmaceutical preparation

Management of breakthrough bleeding in extended hormonal contraceptive regimens